Acorda Therapeutics Inc (ACORQ)

Acorda Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	30.62	44.68	65.22	102.9	105.19
Short-Term Investments	0	0	0	0	63.75
Cash & Cash Equivalents	30.62	44.68	65.22	102.9	168.95
Cash Growth	-31.47%	-31.50%	-36.61%	-39.10%	-62.15%
Receivables	17.3	13.87	17	20.19	22.08
Inventory	16.16	12.75	18.55	28.68	25.22
Other Current Assets	10.73	10.82	1.38	69.57	-15.14
Total Current Assets	74.79	82.12	102.16	221.34	201.11
Property, Plant & Equipment	6.3	7.89	11.13	25.74	165.98
Goodwill and Intangibles	22.99	305.09	335.98	366.98	402.33
Other Long-Term Assets	4.44	0.5	6.2	18.62	30.3
Total Long-Term Assets	33.73	313.48	353.31	411.35	598.61
Total Assets	108.53	395.6	455.47	632.68	799.72
Accounts Payable	13.37	9.81	10.85	12.16	26.26
Deferred Revenue	0.23	0.38	0	0	0
Current Debt	187.73	1.55	8.19	76.58	8.35
Other Current Liabilities	26.44	26.21	34.99	48.52	51.78
Total Current Liabilities	227.77	37.95	54.03	137.25	86.39
Long-Term Debt	3.17	171.37	182.76	183.37	241.27
Other Long-Term Liabilities	35.54	92.65	67.55	74.1	161.25
Total Long-Term Liabilities	38.71	264.02	250.31	257.47	402.51
Total Liabilities	266.48	301.97	304.33	394.73	488.9
Total Debt	190.9	172.92	190.94	259.95	249.61
Debt Growth	10.40%	-9.44%	-26.55%	4.14%	-27.39%
Retained Earnings	-1,189.13	-936.27	-870.36	-766.4	-666.81
Comprehensive Income	1.43	0.63	-1.02	-2.8	-1.17
Shareholders' Equity	-157.96	93.62	151.14	237.96	310.82
Net Cash / Debt	-160.28	-128.24	-125.72	-157.05	-80.67
Net Cash Per Share	-129.05	-126.85	-236.74	-388.56	-203.53
Working Capital	-152.98	44.17	48.13	84.08	114.73
Book Value Per Share	-127.18	92.60	284.60	588.71	784.21

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).